转移性乳腺癌的内科治疗squip 课件.pptVIP

  • 3
  • 0
  • 约4.57万字
  • 约 73页
  • 2018-12-26 发布于四川
  • 举报
* * 1070] Weekly nanoparticle albumin paclitaxel (Abraxane) results in long-term disease control in patients with taxane-refractory metastatic breast cancer. , Blum JL, Sandbach JF, Savin M, Fenske E, Hawkins MJ.. Baylor-Charles A. Sammons Cancer Center, Dallas, TX; US Oncology, Houston, TX; Texas Oncology, P.A., Austin, TX; Texas Oncology, P.A, Plano, TX; American BioScience, Inc., Santa Monica, CA Background: Nanoparticle albumin paclitaxel (Abraxane, ABI-007, ABX) is the first biologically interactive composition exploiting a receptor-mediated (gp60) pathway achieving high intracellular t

文档评论(0)

1亿VIP精品文档

相关文档